Africa & Middle East

The new system increases the Mega Lab’s haematology testing capacity to more than 1,000 tests per hour while reducing manual handling throughout the testing workflow.

Unlike CAR-T therapy, which requires patient-specific cell modification and lengthy manufacturing, this treatment is delivered as a ready-to-use infusion, making it more accessible in standard hospital settings.

Closing this gap would benefit not only patients but also their families and healthcare systems while supporting the Gulf’s broader vision of compassionate, patient-centred care.

The latest accreditation marks another milestone for MTRH, which first earned KENAS accreditation in 2018 and has consistently maintained internationally accepted standards for laboratory testing and pathology services.

The transaction drew robust interest from both regional and international investors, with the orderbook reaching approximately US$1.6 billion, making the offering about 3.2 times oversubscribed.

Developed through a partnership between Masdar City, M42, and Attentive Science, Biosphere Labs aims to address one of the biggest challenges facing researchers and biotechnology companies: access to high-quality laboratory infrastructure.

The new diagnostic approach aligns with recommendations from the European Association of Urology and the American Urological Association.

The collaboration follows the signing of a Memorandum of Understanding and forms part of Saudi Arabia’s broader efforts to enhance preventive healthcare and improve outcomes for people living with chronic diseases.

The vaccine was registered earlier this month by the South African Health Products Regulatory Authority (SAHPRA), paving the way for large-scale importation and commercial distribution.

The strategy aims to enhance national health security, create jobs, promote innovation, and improve access to quality and affordable healthcare commodities while reducing the country’s reliance on imports.